# A Multiple-Ascending-Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Novel GPR40 Agonist, TAK-875, in Subjects With Type 2 Diabetes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-multiple-ascending-dose-study-to-evaluate-safety-pharmacokinetics-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Eckhard Leifke,Himanshu Naik,Jingtao Wu,Prabhakar Viswanathan,Deborah A. DeManno,Mark Kipnes,Majid Vakilynejad |
| Citations | 87 |
| DOI | 10.1038/clpt.2012.43 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2025703258 |
| PMID | 22669289 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Eckhard Leifke](https://scholariq.org/researchers/eckhard-leifke/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.